The 20 Best Chronic Myelogenous Leukemia (CML) Doctors Near Me in Ann Arbor, MI

Dr. Talpaz comes to U-M from the University of Texas M.D. Anderson Cancer Center in Houston, where he was a professor of medicine. His research interests include the study of leukemia and immunotherapy, which uses the immune system to fight cancer. He also treats patients with leukemia. Talpaz will continue his research, expanding the U-M Rogel Cancer Center's efforts in hematologic cancer. He will serve as professor of internal medicine at the U-M Medical School. Dr. Talpaz is rated as an Elite provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Chronic Myelogenous Leukemia (CML), Myeloproliferative Neoplasms (MPN), and Polycythemia Vera. Dr. Talpaz is board certified in Internal Medicine and Medical Oncology.

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology.

Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Dr. Pettit is rated as a Distinguished provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Splenectomy. Dr. Pettit is board certified in Medical Oncology and Hematology.

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Burke is board certified in Hematology and Medical Oncology.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Advanced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Dr. Magenau is currently an Assistant Professor at the University of Michigan and the Adult Clinical BMT director of the Blood and Marrow Transplantation Program. He holds a Bachelor of Science in Biology from Pennsylvania State University, and obtained his M.D. from the Temple University in Philadelphia, Pennsylvania. Dr. Magenau then trained in internal medicine at the University of Illinois in Chicago.Dr. Magenau is the lead clinical investigator on several trials including experience in clinical HCT, responsible research practices, team science, and conducting multicenter prospective HCT clinical trials in high risk populations (Acute Myeloid Leukemia not in remission at time of HCT). He also has a background in developing, performing, and monitoring HCT studies that integrate immune analysis of human samples. Dr. Magenau is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Magenau is board certified in Hematology.

John Maciejewski is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Maciejewski is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Sarah Anand is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Anand is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy. Dr. Anand is board certified in Internal Medicine, Hematology, and Medical Oncology.

Monalisa Ghosh, MD, Assistant Professor. Dr. Ghosh graduated with honors from the University of Alabama at Birmingham with a BS in Biomedical Engineering, minor in Mathematics and Chemistry. She earned her MD from the University of Alabama School of Medicine where she also completed her residency training. Her fellowship training was completed at the NIH/NCI Medical Oncology Fellowship Program. Dr. Ghosh’s research interest is in bone marrow trans-plantation and cellular therapies to treat lymphoma. Dr. Ghosh will be seeing patients on the BMT service. Dr. Ghosh is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Graft Versus Host Disease (GvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Colonoscopy.

Mary Riwes is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Riwes is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Colonoscopy.

Marcus Geer is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Geer is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Transplant. Dr. Geer is board certified in Internal Medicine, Medical Oncology, and Hematology.

Attaphol Pawarode is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Pawarode is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Fine is an honors graduate of Harvard University and the U-M Medical School. He completed his internal medicine residency and served as chief medical resident at the U-M Medical Center. Dr. Fine was cited recently in The Best Doctors in America: Midwest Edition, 2017-2018. He enjoys piano and poetry composition, reading and music.Read Dr. Fine's 8 questions profile. Dr. Fine is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Colonoscopy, and Balloon Sinuplasty.

Darren King is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 18 years. Dr. King is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. King is board certified in Hematology and Medical Oncology.

Dr. Carty completed her undergraduate work at Harvard University, graduating magna cum laude, with a degree in Biochemical Sciences. She attended the Albert Einstein College of Medicine in New York where she earned her MD degree. Dr. Carty stayed in New York for her internal medicine residency at Columbia University Medical Center, and moved to the Hospital of the University of Pennsylvania for her Hematology-Oncology fellowship. She remained on staff at the Hospital of the University of Pennsylvania before moving here to Ann Arbor. Dr. Carty is the recipient of a K08 Award for her work in T cell biology and ASH Scholar Award for her research on T cell lymphomas. Dr. Carty is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Carty is board certified in Hematology.

Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.

Jessie King is a primary care provider, practicing in Internal Medicine and Hospital Medicine in Ann Arbor, Michigan. Dr. King is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Aplastic Anemia, Bone Marrow Aspiration, and Endoscopy. Dr. King is board certified in Internal Medicine.

Dr. Merz is from Spring Lake, MI. She earned a BA in Kinesiology and Spanish at Calvin College before obtaining her MD and Master's of Science in Clinical Research at the University of Michigan. She then completed internal medicine training at Brigham and Women's Hospital in Boston, MA before completing hematology/oncology fellowship at Dana-Farber Cancer Institute/Mass General Brigham.She joined the faculty at University of Michigan in 2025, specializing in women's health and classical hematology disorders like sickle cell disease, blood clots, ITP, or iron deficiency in pregnancy or with hormone therapy use.Dr. Merz's research work includes understanding the Duffy null phenotype-- a red blood cell variant common in people with African or Middle Eastern ancestry. She advocated to update the terminology around this variant to Duffy null-associated neutrophil counts (DANC), published the first Duffy null-specific absolute neutrophil count reference range, and was the principal investigator on a grant through the Doris Duke Foundation and the American Society of Hematology to accelerate the update of Duffy null reference ranges across the country. She now works to understand how to personalize diagnostics and treatment plans for people with the Duffy null variant-- especially in cancer care. She also does research in women's health and classical hematology including understanding how to prevent blood clots in pregnancy and optimizing iron stores throughout the reproductive lifespan.Outside of work, Dr. Merz is an active member in the Ann Arbor community and enjoys spending time with her husband and 2 greyhounds. Dr. Merz is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Agranulocytosis, Chronic Familial Neutropenia, Febrile Neutropenia, Thrombectomy, and Bone Marrow Transplant.

Qing Li is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Li is rated as an Experienced provider by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Promyelocytic Leukemia, and Bone Marrow Aspiration.